PinnyPeptide

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) vs TB-500

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)

Peptide Blends

Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial.

Peptide B

TB-500

Healing & Recovery

Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity.

Typical vial

80 mg

Typical dose

500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg

Half-life

KPV ~minutes; BPC-157 ~4 h; TB-500 ~6-8 h; GHK-Cu ~minutes systemically

FDA status

No component FDA approved for human use. FDA issued a warnin…

Typical vial

5 mg

Typical dose

2000-5000 mcg

Half-life

~6-8 hours

FDA status

Not FDA approved for human use.

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) effects

  • Broad anti-inflammatory action across NF-κB, nitric oxide, and copper-modulation pathways
  • Soft-tissue healing and tendon recovery (BPC + TB contribution)
  • Stimulates collagen synthesis and skin elasticity (GHK-Cu contribution)
  • Anti-inflammatory action in the gut and inflamed skin (KPV contribution)
  • Modulates the gut-skin axis (anecdotal, component-derived)
  • Reduces scar formation and supports remodelling
  • Promotes angiogenesis and improved blood flow to repair sites

TB-500 effects

  • Promotes wound healing and tissue repair
  • Reduces inflammation and fibrosis
  • Stimulates new blood vessel growth
  • Supports cardiac repair after ischemic injury
  • Enhances cell migration through actin upregulation

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) side effects

  • Injection site irritation (occasionally with mild bluish tint from copper)
  • Temporary lightheadedness
  • Mild lethargy in first 1-2 weeks
  • Headache
  • Nausea at upper dosing range
  • Possible flushing from MSH-pathway activity (KPV)

TB-500 side effects

  • Injection site irritation
  • Temporary head rush or lightheadedness
  • Mild lethargy
  • Headache

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) dosing ranges

Inflammation + recovery loading

500 mcg KPV + 250 mcg BPC + 2 mg TB-500 + 1-2 mg GHK-Cu · KPV + BPC + GHK daily, TB-500 twice weekly · 6-8 weeks

Gut-skin axis protocol

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · Daily, with TB-500 weekly · 8-12 weeks

Maintenance

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · KPV + BPC 3-4x weekly, others weekly · Ongoing cycles

TB-500 dosing ranges

Acute injury healing

2000-5000 mcg · Twice weekly · 4-6 weeks

Maintenance and recovery

2000 mcg · Once weekly · 4-8 weeks

Full Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) guide → Full TB-500 guide →

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) vs TB-500 — common questions

What is the difference between Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) and TB-500?

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial. Typical dose 500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg. TB-500: Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity. Typical dose 2000-5000 mcg. Both fall under the Peptide Blends and Healing & Recovery categories.

Can you stack Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) and TB-500?

Stacking Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) with TB-500 is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) or TB-500?

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) is typically dosed: KPV + BPC + GHK daily, TB-500 twice weekly for Inflammation + recovery loading; Daily, with TB-500 weekly for Gut-skin axis protocol; KPV + BPC 3-4x weekly, others weekly for Maintenance. TB-500 is typically dosed: Twice weekly for Acute injury healing; Once weekly for Maintenance and recovery.

Are Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) and TB-500 FDA approved?

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): No component FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products. TB-500: Not FDA approved for human use.

Related peptide comparisons

bpc-157 vs klow-blendghk-cu vs klow-blendglow-blend vs klow-blendklow-blend vs kpvklow-blend vs wolverine-blendara-290 vs tb-500

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free